Cargando…
Predicting the angiotensin converting enzyme 2 (ACE2) utilizing capability as the receptor of SARS-CoV-2
SARS-CoV-2, the newly identified human coronavirus causing severe pneumonia pandemic, was probably originated from Chinese horseshoe bats. However, direct transmission of the virus from bats to humans is unlikely due to lack of direct contact, implying the existence of unknown intermediate hosts. An...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Institut Pasteur. Published by Elsevier Masson SAS.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156207/ https://www.ncbi.nlm.nih.gov/pubmed/32199943 http://dx.doi.org/10.1016/j.micinf.2020.03.003 |
_version_ | 1783522167121510400 |
---|---|
author | Qiu, Ye Zhao, Yuan-Bo Wang, Qiong Li, Jin-Yan Zhou, Zhi-Jian Liao, Ce-Heng Ge, Xing-Yi |
author_facet | Qiu, Ye Zhao, Yuan-Bo Wang, Qiong Li, Jin-Yan Zhou, Zhi-Jian Liao, Ce-Heng Ge, Xing-Yi |
author_sort | Qiu, Ye |
collection | PubMed |
description | SARS-CoV-2, the newly identified human coronavirus causing severe pneumonia pandemic, was probably originated from Chinese horseshoe bats. However, direct transmission of the virus from bats to humans is unlikely due to lack of direct contact, implying the existence of unknown intermediate hosts. Angiotensin converting enzyme 2 (ACE2) is the receptor of SARS-CoV-2, but only ACE2s of certain species can be utilized by SARS-CoV-2. Here, we evaluated and ranked the receptor-utilizing capability of ACE2s from various species by phylogenetic clustering and sequence alignment with the currently known ACE2s utilized by SARS-CoV-2. As a result, we predicted that SARS-CoV-2 tends to utilize ACE2s of various mammals, except murines, and some birds, such as pigeon. This prediction may help to screen the intermediate hosts of SARS-CoV-2. |
format | Online Article Text |
id | pubmed-7156207 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Institut Pasteur. Published by Elsevier Masson SAS. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71562072020-04-15 Predicting the angiotensin converting enzyme 2 (ACE2) utilizing capability as the receptor of SARS-CoV-2 Qiu, Ye Zhao, Yuan-Bo Wang, Qiong Li, Jin-Yan Zhou, Zhi-Jian Liao, Ce-Heng Ge, Xing-Yi Microbes Infect Article SARS-CoV-2, the newly identified human coronavirus causing severe pneumonia pandemic, was probably originated from Chinese horseshoe bats. However, direct transmission of the virus from bats to humans is unlikely due to lack of direct contact, implying the existence of unknown intermediate hosts. Angiotensin converting enzyme 2 (ACE2) is the receptor of SARS-CoV-2, but only ACE2s of certain species can be utilized by SARS-CoV-2. Here, we evaluated and ranked the receptor-utilizing capability of ACE2s from various species by phylogenetic clustering and sequence alignment with the currently known ACE2s utilized by SARS-CoV-2. As a result, we predicted that SARS-CoV-2 tends to utilize ACE2s of various mammals, except murines, and some birds, such as pigeon. This prediction may help to screen the intermediate hosts of SARS-CoV-2. Institut Pasteur. Published by Elsevier Masson SAS. 2020 2020-03-19 /pmc/articles/PMC7156207/ /pubmed/32199943 http://dx.doi.org/10.1016/j.micinf.2020.03.003 Text en © 2020 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Qiu, Ye Zhao, Yuan-Bo Wang, Qiong Li, Jin-Yan Zhou, Zhi-Jian Liao, Ce-Heng Ge, Xing-Yi Predicting the angiotensin converting enzyme 2 (ACE2) utilizing capability as the receptor of SARS-CoV-2 |
title | Predicting the angiotensin converting enzyme 2 (ACE2) utilizing capability as the receptor of SARS-CoV-2 |
title_full | Predicting the angiotensin converting enzyme 2 (ACE2) utilizing capability as the receptor of SARS-CoV-2 |
title_fullStr | Predicting the angiotensin converting enzyme 2 (ACE2) utilizing capability as the receptor of SARS-CoV-2 |
title_full_unstemmed | Predicting the angiotensin converting enzyme 2 (ACE2) utilizing capability as the receptor of SARS-CoV-2 |
title_short | Predicting the angiotensin converting enzyme 2 (ACE2) utilizing capability as the receptor of SARS-CoV-2 |
title_sort | predicting the angiotensin converting enzyme 2 (ace2) utilizing capability as the receptor of sars-cov-2 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156207/ https://www.ncbi.nlm.nih.gov/pubmed/32199943 http://dx.doi.org/10.1016/j.micinf.2020.03.003 |
work_keys_str_mv | AT qiuye predictingtheangiotensinconvertingenzyme2ace2utilizingcapabilityasthereceptorofsarscov2 AT zhaoyuanbo predictingtheangiotensinconvertingenzyme2ace2utilizingcapabilityasthereceptorofsarscov2 AT wangqiong predictingtheangiotensinconvertingenzyme2ace2utilizingcapabilityasthereceptorofsarscov2 AT lijinyan predictingtheangiotensinconvertingenzyme2ace2utilizingcapabilityasthereceptorofsarscov2 AT zhouzhijian predictingtheangiotensinconvertingenzyme2ace2utilizingcapabilityasthereceptorofsarscov2 AT liaoceheng predictingtheangiotensinconvertingenzyme2ace2utilizingcapabilityasthereceptorofsarscov2 AT gexingyi predictingtheangiotensinconvertingenzyme2ace2utilizingcapabilityasthereceptorofsarscov2 |